Cornes P - Search Results

1

Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia.

Cornes P, Gascon P, Chan S, Hameed K, Mitchell CR, Field P, Latymer M, Arantes LH Jr. Cornes P, et al. Adv Ther. 2018 Nov;35(11):1830. doi: 10.1007/s12325-018-0818-6. Adv Ther. 2018. PMID: 30374804 Free PMC article.

2

Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia.

Cornes P, Gascon P, Chan S, Hameed K, Mitchell CR, Field P, Latymer M, Arantes LH Jr. Cornes P, et al. Adv Ther. 2018 Nov;35(11):1816-1829. doi: 10.1007/s12325-018-0798-6. Epub 2018 Oct 8. Adv Ther. 2018. PMID: 30298233 Free PMC article.

3

Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure.

Cornes P, Gascon P, Vulto AG, Aapro M. Cornes P, et al. BioDrugs. 2020 Jun;34(3):255-263. doi: 10.1007/s40259-020-00411-4. BioDrugs. 2020. PMID: 32232676 Free PMC article. Review.

4

Supportive care in patients with cancer during the COVID-19 pandemic.

Aapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascón P, Kuderer NM. Aapro M, et al. Among authors: cornes p. ESMO Open. 2021 Feb;6(1):100038. doi: 10.1016/j.esmoop.2020.100038. Epub 2020 Dec 17. ESMO Open. 2021. PMID: 33421735 Free PMC article. Review.

5

Commentary - A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia.

Cornes PG, Muenzberg M. Cornes PG, et al. Toxicol Appl Pharmacol. 2020 Nov 1;406:115202. doi: 10.1016/j.taap.2020.115202. Epub 2020 Aug 18. Toxicol Appl Pharmacol. 2020. PMID: 32822736

6

Erythropoietins should be used according to guidelines.

Aapro MS, Birgegård G, Bokemeyer C, Cornes P, Foubert J, Gascon P, Glaspy J, Hellström-Lindberg E, Link H, Ludwig H, Osterborg A, Repetto L, Soubeyran P. Aapro MS, et al. Among authors: cornes p. Lancet Oncol. 2008 May;9(5):412-3. doi: 10.1016/S1470-2045(08)70115-3. Lancet Oncol. 2008. PMID: 18452853 No abstract available.

7

Comparative cost-efficiency across the European G5 countries of various regimens of filgrastim, biosimilar filgrastim, and pegfilgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia.

Aapro M, Cornes P, Abraham I. Aapro M, et al. Among authors: cornes p. J Oncol Pharm Pract. 2012 Jun;18(2):171-9. doi: 10.1177/1078155211407367. Epub 2011 May 24. J Oncol Pharm Pract. 2012. PMID: 21610020 Free article.

8

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer.

Aapro M, Cornes P, Sun D, Abraham I. Aapro M, et al. Among authors: cornes p. Ther Adv Med Oncol. 2012 May;4(3):95-105. doi: 10.1177/1758834012444499. Ther Adv Med Oncol. 2012. PMID: 22590483 Free PMC article.

9

The evolution of value with filgrastim in oncology.

Cornes P, Krendyukov A. Cornes P, et al. Future Oncol. 2019 May;15(13):1525-1533. doi: 10.2217/fon-2018-0762. Epub 2019 Mar 5. Future Oncol. 2019. PMID: 30835142 Review.

10

The changing landscape of biosimilars in rheumatology.

Dörner T, Strand V, Cornes P, Gonçalves J, Gulácsi L, Kay J, Kvien TK, Smolen J, Tanaka Y, Burmester GR. Dörner T, et al. Among authors: cornes p. Ann Rheum Dis. 2016 Jun;75(6):974-82. doi: 10.1136/annrheumdis-2016-209166. Epub 2016 Mar 8. Ann Rheum Dis. 2016. PMID: 26964144 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page